
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review
Javier de Diego-Adeliño, José Manuel Crespo, Fernando A. Lázaro Mora, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 5, pp. 673-690
Open Access | Times Cited: 40
Javier de Diego-Adeliño, José Manuel Crespo, Fernando A. Lázaro Mora, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 5, pp. 673-690
Open Access | Times Cited: 40
Showing 26-50 of 40 citing articles:
Vortioxetine reduces the development of pain‐related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down‐regulation
Maja Tomić, Katarina Nastić, Miroslav Dinić, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 24, pp. 5079-5093
Open Access | Times Cited: 1
Maja Tomić, Katarina Nastić, Miroslav Dinić, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 24, pp. 5079-5093
Open Access | Times Cited: 1
A quality by design paradigm, novel, and fast LC-MS/MS method to quantify vortioxetine in rat brain homogenate and its assessment of greenness, whiteness, and blueness tools
Saniye Özcan, Hazal Avcı, Serkan Levent, et al.
Microchemical Journal (2024), pp. 112012-112012
Closed Access | Times Cited: 1
Saniye Özcan, Hazal Avcı, Serkan Levent, et al.
Microchemical Journal (2024), pp. 112012-112012
Closed Access | Times Cited: 1
Effects of Vortioxetine on Sleep Architecture of Adolescents with Major Depressive Disorder
Zuzana Mlyncekova, Peter Hutka, Zuzana Višňovcová, et al.
Clocks & Sleep (2023) Vol. 5, Iss. 4, pp. 627-638
Open Access | Times Cited: 3
Zuzana Mlyncekova, Peter Hutka, Zuzana Višňovcová, et al.
Clocks & Sleep (2023) Vol. 5, Iss. 4, pp. 627-638
Open Access | Times Cited: 3
SYK-623, a δ Opioid Receptor Inverse Agonist, Mitigates Chronic Stress-Induced Behavioral Abnormalities and Disrupted Neurogenesis
Takashi Iwai, Rei Mishima, Shigeto Hirayama, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 608-608
Open Access
Takashi Iwai, Rei Mishima, Shigeto Hirayama, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 608-608
Open Access
Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder
Alessandro Cuomo, G. Barillà, M. Cattolico, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 5, pp. 465-476
Closed Access
Alessandro Cuomo, G. Barillà, M. Cattolico, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 5, pp. 465-476
Closed Access
The dose-response relationship of vortioxetine on major depressive disorder: an umbrella review
Ping Wang, Weiwei Wang, Yiqi Liu, et al.
Psychiatry Research (2024) Vol. 340, pp. 116118-116118
Open Access
Ping Wang, Weiwei Wang, Yiqi Liu, et al.
Psychiatry Research (2024) Vol. 340, pp. 116118-116118
Open Access
Foundations for a Personalized Psycho-Oncology: The State of the Art
Giampaolo Perna, Eleonora Pinto, Alessandro Spiti, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 892-892
Open Access
Giampaolo Perna, Eleonora Pinto, Alessandro Spiti, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 892-892
Open Access
Effectiveness of Vortioxetine Treatment on Depression and Cognitive Functions in Patients with Alzheimer’s Disease: A 12-Month, Retrospective, Observational Study
José María García‐Alberca, Paz de la Guía, Esther Gris, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 918-918
Open Access
José María García‐Alberca, Paz de la Guía, Esther Gris, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 918-918
Open Access
Vortioxetine in the Treatment of Major Depressive Disorder Among Working Patients in Routine Clinical Practice: An Analysis of a Post-Marketing Surveillance Study in South Korea
Seok Woo Moon, Jee Wook Kim, Do Hoon Kim, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2299-2311
Open Access
Seok Woo Moon, Jee Wook Kim, Do Hoon Kim, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2299-2311
Open Access
A Randomized Controlled Study of Efficacy and Cognitive Function Improvement of Vortioxetine and Escitalopram in Patients with Depression in Chinese Han Nationality
X. Ye, Pengfeng Xu, Jianping Jiao, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2363-2374
Open Access
X. Ye, Pengfeng Xu, Jianping Jiao, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2363-2374
Open Access
Simultaneous 5-HT1BR agonist/5-HT6R antagonist action as a potential treatment of Parkinson’s disease and its comorbidities
Paweł Zajdel, Mikołaj Matłoka, Jolanta Konieczny, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 2, pp. 100055-100055
Closed Access
Paweł Zajdel, Mikołaj Matłoka, Jolanta Konieczny, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 2, pp. 100055-100055
Closed Access
Music Medicine for Neurological Disorders
Neelima B. Chauhan, Mahesh Kale, Purva Gujar-Kale, et al.
Integrated science (2024), pp. 811-850
Closed Access
Neelima B. Chauhan, Mahesh Kale, Purva Gujar-Kale, et al.
Integrated science (2024), pp. 811-850
Closed Access
Mental health update – update on depression with a focus on vortioxetine
Barney Jordaan
SA pharmaceutical journal. (2024) Vol. 91, Iss. 6, pp. 26-30
Closed Access
Barney Jordaan
SA pharmaceutical journal. (2024) Vol. 91, Iss. 6, pp. 26-30
Closed Access
Adherence to Antidepressants in Korean Elderly Patients with Major Depressive Disorder
Kyung Ju Lee, Yu Jeung Lee
Korean Journal of Clinical Pharmacy (2023) Vol. 33, Iss. 1, pp. 62-69
Open Access | Times Cited: 1
Kyung Ju Lee, Yu Jeung Lee
Korean Journal of Clinical Pharmacy (2023) Vol. 33, Iss. 1, pp. 62-69
Open Access | Times Cited: 1
Antidepressants and Sexual Dysfunction: Is Vortioxetine Among the Exceptions?
TS Sathyanarayana Rao, Chittaranjan Andrade
Journal of Psychosexual Health (2022) Vol. 4, Iss. 3, pp. 155-156
Open Access | Times Cited: 1
TS Sathyanarayana Rao, Chittaranjan Andrade
Journal of Psychosexual Health (2022) Vol. 4, Iss. 3, pp. 155-156
Open Access | Times Cited: 1
Mechanisms of action and clinical effects of vortioxetine
Н. Н. Петрова, A A Mukhin
S S Korsakov Journal of Neurology and Psychiatry (2022) Vol. 122, Iss. 6, pp. 84-84
Closed Access
Н. Н. Петрова, A A Mukhin
S S Korsakov Journal of Neurology and Psychiatry (2022) Vol. 122, Iss. 6, pp. 84-84
Closed Access